This week it was announced the Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for their drug Bedaquiline (a.k.a. TMC-207). For additional information on Bedaquiline, visit our online Global TB Drug Pipeline where there are two projects on Bedaquiline–http://www.newtbdrugs.org/project.php?id=141 and http://www.newtbdrugs.org/project.php?id=125.
Related News Coverage:
Additional TB R&D News: